153
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A 5-Year Follow-Up Study to Explore Factors Associated with Rapid Kidney Function Decline Among Bus Drivers

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 3193-3201 | Received 09 May 2023, Accepted 21 Jul 2023, Published online: 28 Jul 2023

References

  • Golinko V, Cheberyachko S, Deryugin O, et al. Assessment of the risks of occupational diseases of the passenger bus drivers. Saf Health Work. 2020;11:543–549. doi:10.1016/j.shaw.2020.07.005
  • Remembering responsibility to give bus drivers a sense of professional honor. Nanfan Daily; 2021. Available from: https://www.chinabuses.com/keyun/2021/0303/article_97661.html. Accessed March 13, 2022.
  • Chen CF, Hsu YC. Taking a closer look at bus driver emotional exhaustion and well-being: evidence from Taiwanese urban bus drivers. Saf Health Work. 2020;11:353–360. doi:10.1016/j.shaw.2020.06.002
  • Tu ZH, He JW, Zhou N, et al. Driver-passenger communicative stress and psychological distress among Chinese bus drivers: the mediating effect of job burnout. BMC Public Health. 2021;21:547. doi:10.1186/s12889-021-10618-x
  • Wu WT, Tsai SS, Wang CC, et al. Professional driver’s job stress and 8-year risk of cardiovascular disease: the Taiwan bus driver cohort study. Epidemiology. 2019;30:S39–S47. doi:10.1097/EDE.0000000000001003
  • Mohsen A, Hakim S. Workplace stress and its relation to cardiovascular disease risk factors among bus drivers in Egypt. East Mediterr Health J. 2019;25(12):878–886. doi:10.26719/emhj.19.056
  • Kasemsan A, Joseph L, Paungmali A, et al. Prevalence of musculoskeletal pain and associated disability among professional bus drivers: a cross‑sectional study. Int Arch Occ Env Hea. 2021;4:1263–1270. doi:10.1007/s00420-021-01683-1
  • Meng CQ, Nie Q, Zhang XL, et al. 石家庄市职业性公交车司机健康状况调查及性别、年龄差异分析 [Survey on health status of professional bus drivers and variation analysis of gender and age in Shijiazhuang City] . Hebei Med J. 2022;3:456–459. Chinese.
  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765
  • Kritmetapak K, Charoensri S, Thaopanya R, et al. Elevated serum uric acid is associated with rapid decline in kidney function: a 10-year follow-up study. Int J Gen Med. 2020;13:945–953. doi:10.2147/IJGM.S277957
  • Jager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019;34:1803–1805. doi:10.1093/ndt/gfz174
  • Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395:709–733. doi:10.1016/S0140-6736(20)30045-3
  • Guan H, Zheng Y, Zhou X, et al. Efficacy of different urinary uric acid indicators in patients with chronic kidney disease. BMC Nephrol. 2020;21(1):290. doi:10.1186/s12882-020-01953-z
  • Hirst JA, Montes MDV, Taylor CJ, et al. Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care. Br J Gen Pract. 2018;68(673):e524–e530. doi:10.3399/bjgp18X697937
  • Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33(4):278–285. doi:10.1111/j.1532-5415.1985.tb07117.x
  • Rifkin DE, Shlipak MG, Katz R, et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med. 2008;168(20):2212–2218. doi:10.1001/archinte.168.20.2212
  • Silva NR, Gonçalves CET, Gonçalves DLN, et al. Association of uric acid and uric acid to creatinine ratio with chronic kidney disease in hypertensive patients. BMC Nephrol. 2021;22(1):311. doi:10.1186/s12882-021-02521-9
  • Shibata Y, Yamazaki M, Kitahara J, et al. Changes in serum uric acid levels as a predictor of future decline in renal function in older adults with type 2 diabetes. Medicine. 2021;100(40):e27420. doi:10.1097/MD.0000000000027420
  • Bonino B, Leoncini G, Russo E, et al. Uric acid in CKD: has the jury come to the verdict? J Nephrol. 2020;33:715–724. doi:10.1007/s40620-020-00702-7
  • Kuwabara M, Bjornstad P, Hisatome I, et al. Elevated serum uric acid level predicts rapid decline in kidney function. Am J Nephrol. 2017;45(4):330–337. doi:10.1159/000464260
  • Di Bonito P, Valerio G, Licenziati MR, et al. High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity. J Endocrinol Invest. 2020;43(4):461–468. doi:10.1007/s40618-019-01130-6
  • Xu Y, Liu X, Sun X, et al. The impact of serum uric acid on the natural history of glomerular filtration rate: a retrospective study in the general population. Peer J. 2016;4:e1859. doi:10.7717/peerj.1859
  • Zeng C, Cheng D, Sheng X, et al. Increased serum uric acid level is a risk factor for left ventricular hypertrophy but not independent of eGFR in patients with type 2 diabetic kidney disease. J Diabetes Res. 2017;2017:5016093. doi:10.1155/2017/5016093
  • Ohta Y, Tsuchihashi T, Kiyohara K, et al. Increased uric acid promotes decline of the renal function in hypertensive patients: a 10-year observational study. Intern Med. 2013;52(13):1467–1472. doi:10.2169/internalmedicine.52.0141
  • Oliveira IO, Mintem GC, Oliveira PD, et al. Uric acid is independent and inversely associated to glomerular filtration rate in young adult Brazilian individuals. Nutr Metab Cardiovasc Dis. 2020;30(8):1289–1298. doi:10.1016/j.numecd.2020.04.016
  • Kawamoto R, Ninomiya D, Akase T, et al. Interactive association of baseline and changes in serum uric acid on renal dysfunction among community-dwelling persons. J Clin Lab Anal. 2020;34(5):e23166. doi:10.1002/jcla.23166
  • Xiong J, Zheng X, Luo J, et al. A follow-up study to explore factors associated with rapid kidney function decline and new-onset kidney disease among Chinese elderly population. Geriatr Gerontol Int. 2022:1–8. doi:10.1111/ggi.14480.
  • Tao M, Pi X, Ma X, et al. Relationship between serum uric acid and clustering of cardiovascular disease risk factors and renal disorders among Shanghai population: a multicentre and cross-sectional study. BMJ Open. 2019;9(3):e025453. doi:10.1136/bmjopen-2018-025453
  • Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17–28. doi:10.1038/ki.2010.483
  • CDC. Measure your blood pressure; 2021. Available from: https://www.cdc.gov/bloodpressure/measure.htm. Accessed April 4, 2022.
  • Wang YF, Ma ZM, Xu CN, et al. Prediction of transfer among multiple states of blood pressure based on Markov model: an 18-year cohort study. J Hypertens. 2018;36:15061513. doi:10.1097/HJH.0000000000001722
  • The WHO STEPwise approach to non-communicable disease risk factor surveillance. WHO STEPS surveillance manual. BMI Classification Chart. World Health Organization; 2017. Available from: https://cdn.who.int/media/docs/default-source/ncds/ncd-surveillance/steps/steps-manual_f0075411-1e6d-46ef-85befe826d2b9c47.pdf?sfvrsn=c281673d_5. Accessed April 22, 2022.
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: di-agnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  • Wan Z, Song L, Hu L, et al. Temporal trends in hyperuricaemia among adults in Wuhan city, China, from 2010 to 2019: a cross-sectional study. BMJ Open. 2021;11(3):e043917. doi:10.1136/bmjopen-2020-043917
  • Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820. doi:10.1155/2015/762820
  • Virdis A, Masi S, Casiglia E, et al. Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years. Hypertension. 2020;75(2):302–308. doi:10.1161/HYPERTENSIONAHA.119.13643
  • Wang H, Wei Y, Kong X, et al. Effects of urate-lowering therapy in hyperuricemia on slowing the progression of renal function: a meta-analysis. J Ren Nutr Offic J Counc Ren Nutr Natl Kidn Found. 2013;23(5):389e96. doi:10.1053/j.jrn.2012.08.005
  • Fujii R, Yamada H, Tsuboi Y, et al. Association between circulating microRNAs and changes in kidney function: a five-year prospective study among Japanese adults without CKD. Clin Chim Acta. 2021;521:97–103. doi:10.1016/j.cca.2021.07.002
  • Yan G, Zhao W-H, Wan Y, Ren J-H, Shen J-H. Risk factor analysis of the decline in the estimated glomerular filtration rate in a healthy population. J Biol Regul Homeost Agents. 2023;37(5):2733–2737. doi:10.23812/j.biol.regul.homeost.agents.20233705.270
  • Whelton A, MacDonald PA, Chefo S, et al. Preservation of renal function during gout treatment with febuxostat: a quantitative study. Postgrad Med. 2013;125(1):106–114. doi:10.3810/pgm.2013.01.2626
  • Lin YC, Lai TS, Lin SL, Chen YM, Chu TS, Tu YK. The impact of baseline glomerular filtration rate on subsequent changes of glomerular filtration rate in patients with chronic kidney disease. Sci Rep. 2021;11(1):7894. doi:10.1038/s41598-021-86955-z
  • Melsom T, Nair V, Schei J, et al. Correlation between baseline GFR and subsequent change in GFR in Norwegian adults without diabetes and in Pima Indians. Am J Kidney Dis. 2019;73(6):777–785. doi:10.1053/j.ajkd.2018.11.011
  • Kilbride HS, Stevens PE, Eaglestone G, et al. Accuracy of the MDRD (modification of diet in renal disease) study and CKD-EPI (CKD epidemiology collaboration) equations for estimation of GFR in the elderly. Am J Kidney Dis. 2013;61(1):57–66. doi:10.1053/j.ajkd.2012.06.016
  • Xin Chakkarwar VA, Kawtikwar P. Fenofibrate prevents nicotine-induced acute kidney injury: possible involvement of endothelial nitric oxide synthase. Indian J Nephrol. 2021;31(5):435–441. doi:10.4103/ijn.IJN_380_20